Naomi Kiyota

Incidence of Cancer-Associated Venous Thromboembolism in Patients With Solid Cancers in Japan　- A Prospective Study.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: August 19, 2026

Darolutamide Alone and in Combination With Goserelin in Androgen Receptor-Positive Salivary Gland Carcinoma: Results From the Phase II DISCOVARY Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 03, 2026

Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 26, 2026

A multicenter randomized phase III trial to evaluate the value of omission of elective neck dissection for T3-T4aN0 laryngeal cancer: JCOG2407 (JALNECK).

Journal: Japanese journal of clinical oncology

Published: May 17, 2026

Prospective Predictors of Poor Emotional Functioning in Patients with Differentiated Thyroid Carcinoma.

Journal: Thyroid : official journal of the American Thyroid Association

Published: April 13, 2026

A study to learn how well the combination of encorafenib and binimetinib works and how safe it is in adults with thyroid cancer: a plain language summary.

Journal: Future oncology (London, England)

Published: March 24, 2026

Encorafenib plus binimetinib for BRAF V600-mutated thyroid cancer in Japan: final analysis.

Journal: International journal of clinical oncology

Published: March 12, 2026

A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY).

Journal: Japanese journal of clinical oncology

Published: March 07, 2026

Current status and future perspectives of treatment de-escalation in localized head and neck cancer.

Journal: Japanese journal of clinical oncology

Published: March 06, 2026

Risk factors for aspiration pneumonia related to postoperative chemoradiotherapy for high-risk head and neck cancer: A supplementary analysis of a phase II/III JCOG1008 trial.

Journal: Oral oncology

Published: February 02, 2026

Non-surgical definitive treatment and geriatric assessment in older patients with locally advanced head and neck cancer.

Journal: Japanese journal of clinical oncology

Published: January 31, 2026

Superselective intra-arterial chemoradiotherapy for maxillary sinus squamous-cell carcinoma: results from the T4bN0M0 cohort of JCOG1212.

Journal: ESMO open

Published: January 27, 2026

Incidence of Cancer-Associated Venous Thromboembolism in Patients With Solid Cancers in Japan - A Prospective Study.

Incidence of Cancer-Associated Venous Thromboembolism in Patients With Solid Cancers in Japan - A Prospective Study.

Darolutamide Alone and in Combination With Goserelin in Androgen Receptor-Positive Salivary Gland Carcinoma: Results From the Phase II DISCOVARY Trial.

Darolutamide Alone and in Combination With Goserelin in Androgen Receptor-Positive Salivary Gland Carcinoma: Results From the Phase II DISCOVARY Trial.

Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck Cancer.

Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck Cancer.

A multicenter randomized phase III trial to evaluate the value of omission of elective neck dissection for T3-T4aN0 laryngeal cancer: JCOG2407 (JALNECK).

A multicenter randomized phase III trial to evaluate the value of omission of elective neck dissection for T3-T4aN0 laryngeal cancer: JCOG2407 (JALNECK).

Prospective Predictors of Poor Emotional Functioning in Patients with Differentiated Thyroid Carcinoma.

Prospective Predictors of Poor Emotional Functioning in Patients with Differentiated Thyroid Carcinoma.

A study to learn how well the combination of encorafenib and binimetinib works and how safe it is in adults with thyroid cancer: a plain language summary.

A study to learn how well the combination of encorafenib and binimetinib works and how safe it is in adults with thyroid cancer: a plain language summary.

Encorafenib plus binimetinib for BRAF V600-mutated thyroid cancer in Japan: final analysis.

Encorafenib plus binimetinib for BRAF V600-mutated thyroid cancer in Japan: final analysis.

A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY).

A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY).

Current status and future perspectives of treatment de-escalation in localized head and neck cancer.

Current status and future perspectives of treatment de-escalation in localized head and neck cancer.

Risk factors for aspiration pneumonia related to postoperative chemoradiotherapy for high-risk head and neck cancer: A supplementary analysis of a phase II/III JCOG1008 trial.

Risk factors for aspiration pneumonia related to postoperative chemoradiotherapy for high-risk head and neck cancer: A supplementary analysis of a phase II/III JCOG1008 trial.

Non-surgical definitive treatment and geriatric assessment in older patients with locally advanced head and neck cancer.

Non-surgical definitive treatment and geriatric assessment in older patients with locally advanced head and neck cancer.

Superselective intra-arterial chemoradiotherapy for maxillary sinus squamous-cell carcinoma: results from the T4bN0M0 cohort of JCOG1212.

Superselective intra-arterial chemoradiotherapy for maxillary sinus squamous-cell carcinoma: results from the T4bN0M0 cohort of JCOG1212.

Incidence of Cancer-Associated Venous Thromboembolism in Patients With Solid Cancers in Japan　- A Prospective Study.

Incidence of Cancer-Associated Venous Thromboembolism in Patients With Solid Cancers in Japan　- A Prospective Study.